Lawsuit Against Bristol Myers Over Delayed Cancer Drug Is Revived
Kort samengevat
A U.S. federal appeals court said a judge erred in dismissing a $6.7 billion lawsuit accusing Bristol Myers Squibb of cheating former Celgene shareholders by delaying...
Verder lezen bij de bron
Bekijk het volledige nieuwsbericht rechtstreeks bij Medscape.
Lees het volledige bericht ↗